<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A715CB4E-6888-4FE7-92F3-7C01A22A4C29"><gtr:id>A715CB4E-6888-4FE7-92F3-7C01A22A4C29</gtr:id><gtr:name>STFC - Laboratories</gtr:name><gtr:address><gtr:line1>Rutherford Appleton Laboratory</gtr:line1><gtr:line2>Harwell Science and Innovation Campus</gtr:line2><gtr:line3>Chilton</gtr:line3><gtr:line4>Didcot</gtr:line4><gtr:postCode>OX11 0QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A715CB4E-6888-4FE7-92F3-7C01A22A4C29"><gtr:id>A715CB4E-6888-4FE7-92F3-7C01A22A4C29</gtr:id><gtr:name>STFC - Laboratories</gtr:name><gtr:address><gtr:line1>Rutherford Appleton Laboratory</gtr:line1><gtr:line2>Harwell Science and Innovation Campus</gtr:line2><gtr:line3>Chilton</gtr:line3><gtr:line4>Didcot</gtr:line4><gtr:postCode>OX11 0QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles/><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15021"><gtr:id>52FB1BFF-6AD6-4BF6-9608-19CB2C286778</gtr:id><gtr:title>Diamond Phase 2</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15021</gtr:grantReference><gtr:abstractText>Diamond will be an outstanding source of synchrotron radiation and unique, for medium energy sources, in terms of the number and brightness of the insertion devices. It will be the main source for synchrotron radiation research in the UK. Its impact in world science and the support to the UK research community will be enhanced by the interaction with, and the support provided by other centres on the RAL site: ISIS, the Central Laser Facility and the Centre for Instrumentation Development.

Phase II involves the construction of fourteen user beamlines and one test beamline. The beamlines will be of international standard and will support a wide and important research programme. Diamond will be several orders of magnitude brighter than the SRS, and competitive with the ESRF over much of the photon energy range. To maximise the return on investment, the beamlines must be designed as a whole, from the delivery of radiation to the processing of experimental data. To handle the high flux levels that will be delivered, and to probe matter on faster time scales and at greater levels of reliability, new detectors should be built that are matched to the source and the experiment.</gtr:abstractText><gtr:technicalSummary>12. Phase II will provide one test beamline and fourteen user beamlines, namely:

i. Non-crystalline Diffraction
ii. Test beamline
iii. Small Molecule X-ray Diffraction
iv. High Resolution Powder Diffraction
v. Microfocus Macromolecular Crystallography
vi. Circular Dichroism Spectroscopy
vii. Joint Engineering, Environmental and Processing: JEEP
viii. Monochromatic Macromolecular Crystallography Side-Station
ix. Versatile X-ray Spectrometer: XAS-3
x. Infrared Spectromicroscopy
xi. Surface &amp;amp; Interface Diffraction
xii. Monochromatic Macromolecular Crystallography Side-Station (awaiting SAC approval)
xiii. Coherence &amp;amp; Imaging (awaiting SAC approval) 
xiv. Surface &amp;amp; Interface Structure Analysis: SISA
xv. Core EXAFS</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>4200000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15021</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>